Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Non-Current Debt (2018 - 2026)

TELA Bio has reported Non-Current Debt over the past 7 years, most recently at $55.7 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 35.33% year-over-year to $55.7 million; the TTM value through Dec 2025 reached $55.7 million, up 35.33%, while the annual FY2025 figure was $55.7 million, 35.33% up from the prior year.
  • Non-Current Debt for Q4 2025 was $55.7 million at TELA Bio, up from $41.5 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $55.7 million in Q4 2025 and troughed at $31.5 million in Q4 2021.
  • A 5-year average of $40.7 million and a median of $40.4 million in 2023 define the central range for Non-Current Debt.
  • On a YoY basis, Non-Current Debt climbed as much as 35.33% in 2025 and fell as far as 6.78% in 2025.
  • Year by year, Non-Current Debt stood at $31.5 million in 2021, then increased by 26.75% to $39.9 million in 2022, then rose by 1.5% to $40.5 million in 2023, then rose by 1.5% to $41.1 million in 2024, then skyrocketed by 35.33% to $55.7 million in 2025.
  • Business Quant data shows Non-Current Debt for TELA at $55.7 million in Q4 2025, $41.5 million in Q3 2025, and $38.1 million in Q2 2025.